154 related articles for article (PubMed ID: 26734864)
1. Systemic lupus erythematosus and Raynaud's phenomenon.
Heimovski FE; Simioni JA; Skare TL
An Bras Dermatol; 2015; 90(6):837-40. PubMed ID: 26734864
[TBL] [Abstract][Full Text] [Related]
2. Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?
Caccavo D; Del Porto F; Garzia P; Mitterhofer AP; Galluzzo S; Rigon A; Vadacca M; Navajas MF; Amoroso A; Afeltra A
Ann Rheum Dis; 2003 Oct; 62(10):1003-5. PubMed ID: 12972482
[TBL] [Abstract][Full Text] [Related]
3. Raynaud's phenomenon in systemic lupus erythematosus.
Lavras Costallat LT; Valente Coimbra AM
Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to hn-RNP protein A1 in systemic lupus erythematosus: clinical association with Raynaud's phenomenon and esophageal dysmotility.
Montecucco C; Caporali R; Cobianchi F; Negri C; Astaldi-Ricotti GC
Clin Exp Rheumatol; 1992; 10(3):223-7. PubMed ID: 1582066
[TBL] [Abstract][Full Text] [Related]
5. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen.
Winn DM; Wolfe JF; Lindberg DA; Fristoe FH; Kingsland L; Sharp GC
Arthritis Rheum; 1979 Dec; 22(12):1334-7. PubMed ID: 391237
[TBL] [Abstract][Full Text] [Related]
6. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients.
Furtado RN; Pucinelli ML; Cristo VV; Andrade LE; Sato EI
Lupus; 2002; 11(1):35-41. PubMed ID: 11899953
[TBL] [Abstract][Full Text] [Related]
7. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
[TBL] [Abstract][Full Text] [Related]
8. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
[TBL] [Abstract][Full Text] [Related]
9. Severe Raynaud's phenomenon in a patient with antinuclear antibody-negative systemic lupus erythematosus.
Maxwell CJ; Potter E; Townsend J
J Natl Med Assoc; 1988 May; 80(5):594-5. PubMed ID: 3262169
[TBL] [Abstract][Full Text] [Related]
10. Association of neutrophil extracellular trap levels with Raynaud's phenomenon, glomerulonephritis and disease index score in SLE patients from Brazil.
Delabio Auer E; Bumiller-Bini Hoch V; Borges da Silva E; Ricci Zonta Y; Alarcão Dias-Melicio L; Larocca Skare T; F Picceli V; Messias-Reason IJ; Boldt ABW
Immunobiology; 2024 May; 229(3):152803. PubMed ID: 38640572
[TBL] [Abstract][Full Text] [Related]
11. Critical peripheral ischemia precipitated by severe episode of Raynaud's phenomenon in a patient with aPL-positive systemic lupus erythematosus, upon high titer anti-RNP seroconversion.
Levy O; Maslakov I; Vosco S; Markov A; Amit-Vazina M; Tishler M
Lupus; 2015 Mar; 24(3):327-30. PubMed ID: 25467391
[TBL] [Abstract][Full Text] [Related]
12. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
13. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody activity of cryoglobulins and sera in systemic lupus erythematosus. Association of IgM class rheumatoid factors with Raynaud's syndrome.
Gripenberg M; Teppo AM; Kurki P; Gripenberg G; Helve T
Scand J Rheumatol; 1988; 17(4):249-54. PubMed ID: 3263699
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations.
Tikly M; Burgin S; Mohanlal P; Bellingan A; George J
Clin Rheumatol; 1996 May; 15(3):261-5. PubMed ID: 8793257
[TBL] [Abstract][Full Text] [Related]
16. [Mucocutaneous lesions in patients with systemic lupus erythematosus].
Saurit V; Campana R; Ruiz Lascano A; Ducasse C; Bertoli A; Agüero S; Alvarellos A; Caeiro F
Medicina (B Aires); 2003; 63(4):283-7. PubMed ID: 14518140
[TBL] [Abstract][Full Text] [Related]
17. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE.
Vitali C; Bencivelli W; Isenberg DA; Smolen JS; Snaith ML; Sciuto M; d'Ascanio A; Bombardieri S
Clin Exp Rheumatol; 1992; 10(5):527-39. PubMed ID: 1458709
[TBL] [Abstract][Full Text] [Related]
18. Increased urotensin-II activity in patients with Raynaud's phenomenon and systemic lupus erythematosus.
Buyukhatipoglu H; Buyukaslan H; Pehlivan Y; Ceylan N; Ulas T; Tarakcioglu M; Onat AM
Int J Rheum Dis; 2011 Aug; 14(3):276-81. PubMed ID: 21816024
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Wigley FM; Malamet R; Wise RA
J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus.
Dimant J; Ginzler E; Schlesinger M; Sterba G; Diamond H; Kaplan D; Weiner M
Arthritis Rheum; 1979 Aug; 22(8):815-9. PubMed ID: 465096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
